Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson’s disease

Submitted: 18 November 2014
Accepted: 18 November 2014
Published: 31 October 2012
Abstract Views: 1155
PDF: 1402
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

We describe a case of nephrotic syndrome (NS) after a 7 months treatment with D-penicillamine in a 14 years old girl with Wilson’s disease , with a prompt regression at the discontinuation of the drug. Kidney function, proteinuria in particular, must be always monitored during the chelating therapy, and the drug must be discontinued as soon as signs of renal injury are detected.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Farallo, M., Amoruso, C., Frattini, C., Ardissino, G., & Nebbia, G. (2012). Nephrotic syndrome after treatment with d-penicillamine in a pediatric patient with Wilson’s disease. La Pediatria Medica E Chirurgica, 34(5). https://doi.org/10.4081/pmc.2012.60

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.